How Can Employers Make Pricey Gene Therapies and Specialty Drugs Less Costly?

A recent survey found that several large American firms plan to employ a variety of strategies to mitigate expenses and possibly erect barriers to access for new drugs whose costs can run in the seven figures. For example, employers can delay putting drugs on their formulary until safety and efficacy have been fully vetted by a pharmacy manager. Read more here.

(Source: Ed Silverman, Stat, August 27, 2020)